<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Pathology Publications and Presentations</title>
<copyright>Copyright (c) 2013 University of Massachusetts Medical School All rights reserved.</copyright>
<link>http://escholarship.umassmed.edu/pathology_pp</link>
<description>Recent documents in Pathology Publications and Presentations</description>
<language>en-us</language>
<lastBuildDate>Thu, 21 Mar 2013 11:30:41 PDT</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>Human CD4+ T cell response to human herpesvirus 6</title>
<link>http://escholarship.umassmed.edu/pathology_pp/15</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/15</guid>
<pubDate>Wed, 20 Jun 2012 12:38:10 PDT</pubDate>
<description>
	<![CDATA[
	<p>Following primary infection, human herpesvirus 6 (HHV-6) establishes a persistent infection for life. HHV-6 reactivation has been associated with transplant rejection, delayed engraftment, encephalitis, muscular dystrophy, and drug-induced hypersensitivity syndrome. The poor understanding of the targets and outcome of the cellular immune response to HHV-6 makes it difficult to outline the role of HHV-6 in human disease. To fill in this gap, we characterized CD4 T cell responses to HHV-6 using peripheral blood mononuclear cell (PBMC) and T cell lines generated from healthy donors. CD4(+) T cells responding to HHV-6 in peripheral blood were observed at frequencies below 0.1% of total T cells but could be expanded easily in vitro. Analysis of cytokines in supernatants of PBMC and T cell cultures challenged with HHV-6 preparations indicated that gamma interferon (IFN-γ) and interleukin-10 (IL-10) were appropriate markers of the HHV-6 cellular response. Eleven CD4(+) T cell epitopes, all but one derived from abundant virion components, were identified. The response was highly cross-reactive between HHV-6A and HHV-6B variants. Seven of the CD4(+) T cell epitopes do not share significant homologies with other known human pathogens, including the closely related human viruses human herpesvirus 7 (HHV-7) and human cytomegalovirus (HCMV). Major histocompatibility complex (MHC) tetramers generated with these epitopes were able to detect HHV-6-specific T cell populations. These findings provide a window into the immune response to HHV-6 and provide a basis for tracking HHV-6 cellular immune responses.</p>

	]]>
</description>

<author>Maria-Dorothea Nastke et al.</author>


<category>Antigens, Viral</category>

<category>CD4-Positive T-Lymphocytes</category>

<category>Cell Line</category>

<category>Cross Reactions</category>

<category>Cytokines</category>

<category>Epitopes, T-Lymphocyte</category>

<category>HLA-DR1 Antigen</category>

<category>Haplotypes</category>

<category>Herpesvirus 6, Human</category>

<category>Humans</category>

<category>Interferon-gamma</category>

<category>Leukocytes, Mononuclear</category>

<category>Peptides</category>

<category>Protein Multimerization</category>

<category>Roseolovirus Infections</category>

<category>T-Lymphocytes</category>

<category>T-Lymphocytes, Cytotoxic</category>

<category>Tissue Donors</category>

<category>Viral Load</category>

</item>






<item>
<title>Analysis of ThinPrep cytology in establishing the diagnosis of small cell carcinoma of lung</title>
<link>http://escholarship.umassmed.edu/pathology_pp/14</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/14</guid>
<pubDate>Fri, 03 Sep 2010 06:15:15 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: ThinPrep liquid-based cytology (TP) preparations are being used increasingly in nongynecologic specimens. To the authors' knowledge, few studies to date have evaluated TP cytology in the setting of small cell carcinoma of the lung (SCCL). Accurately differentiating SCCL from other lung tumors has important clinical and therapeutic implications. Herein, the authors evaluated the diagnostic utility and cytomorphology of TP in the setting of SCCL.</p>
<p>METHODS: All cases of SCCL with prior or concurrent TP cytologic specimens were identified via computer search. The cytodiagnoses were tabulated. When available, cytologic material was reviewed. Performance parameters of the various cytologic modalities processed with TP were calculated.</p>
<p>RESULTS: In 121 patients with SCCL, 261 TP specimens were identified. The cytodiagnoses were: SCCL (119 specimens), suspicious for SCCL (45 specimens), atypical cells-not otherwise specified (22 specimens), negative/nondiagnostic (63 specimens), and nonsmall cell carcinoma (4 specimens). During the same period of time, 3 cases of false-positive diagnoses of SCCL were identified. The positive predictive value for a cytodiagnosis of SCCL on TP was 97.5%, and the sensitivity was 62.8%. Bronchial brush was the most sensitive cytologic modality (78.3%). Immunostaining was found to be contributory to the diagnosis in 10 of the 11 cases in which it was attempted.</p>
<p>CONCLUSIONS: TP is a sound alternative to conventional preparations for the cytodiagnosis of SCCL. Cytomorphology of SCCL is altered in TP with less molding, less cell fragility, more discohesion, and tumor cell shrinkage artifact. Immunohistochemical staining of cellblocks is a useful adjunct in challenging cases. A positive cytodiagnosis of SCCL on TP can be used to initiate definitive therapy when biopsy is not possible.</p>

	]]>
</description>

<author>Stacey Kim et al.</author>


<category>Biopsy, Fine-Needle</category>

<category>Cytodiagnosis</category>

<category>Cytological Techniques</category>

<category>False Positive Reactions</category>

<category>Humans</category>

<category>Lung Neoplasms</category>

<category>Sensitivity and Specificity</category>

<category>Small Cell Lung Carcinoma</category>

</item>






<item>
<title>Intrapancreatic schwannoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration cytology</title>
<link>http://escholarship.umassmed.edu/pathology_pp/13</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/13</guid>
<pubDate>Fri, 03 Sep 2010 06:15:15 PDT</pubDate>
<description>
	<![CDATA[
	<p>Schwannoma is a tumor of neuro-ectodermal origin, usually occuring in the head and neck and extremities. A retroperitoneal, and particularly intra-pancreatic presentation is very rare, and poses a clinical and diagnostic challenge. We report a case of a male patient who underwent an Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) biopsy of a hypoechoic, intra-pancreatic mass. The onsite cytological evaluation was consistent with a spindle cell neoplasm. Further evaluation, aided by immunohistochemical stains, defined the mass as a Schwannoma. The patient then underwent a pancreaticoduodenectomy and the histopathological diagnosis of the surgical specimen confirmed the cytological diagnosis. To our knowledge, this is the first report of intra-pancreatic Schwannoma diagnosed preoperatively by EUS-FNA cytology.</p>

	]]>
</description>

<author>Shaoying Li et al.</author>


<category>Adult</category>

<category>Biopsy, Fine-Needle</category>

<category>Collagen Type IV</category>

<category>Endoscopy</category>

<category>Humans</category>

<category>Male</category>

<category>Neurilemmoma</category>

<category>Pancreatic Neoplasms</category>

<category>Proto-Oncogene Proteins c-kit</category>

<category>S100 Proteins</category>

</item>






<item>
<title>An atypical case of fatal zygomycosis: simultaneous cutaneous and laryngeal infection in a patient with a non-neutropenic solid prostatic tumor</title>
<link>http://escholarship.umassmed.edu/pathology_pp/12</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/12</guid>
<pubDate>Fri, 03 Sep 2010 06:15:14 PDT</pubDate>
<description>
	<![CDATA[
	<p>We describe what we believe is the first reported case of simultaneous highly invasive cutaneous and laryngopharyngeal zygomycosis in a non-neutropenic, nondiabetic but immunosuppressed patient with prostate cancer. An invasive fungal process was not suspected until late in the patient's hospital course; when it was, a tracheotomy and direct laryngoscopic biopsies were performed. Unresectable invasive zygomycosis with Rhizopus rhizopodiformis was diagnosed. The patient was managed with liposomal amphotericin B initially and later with palliative medical therapy until he died. This case emphasizes the need for a rapid and specific diagnosis with timely introduction of appropriate antifungal management, particularly now that voriconazole is frequently used as empiric prophylaxis against aspergillosis in high-risk patients.</p>

	]]>
</description>

<author>Kristine E. Johnson et al.</author>


<category>Aged</category>

<category>Dermatomycoses</category>

<category>Fatal Outcome</category>

<category>Humans</category>

<category> *Immunocompromised Host</category>

<category>Laryngeal Diseases</category>

<category>Male</category>

<category>Mucormycosis</category>

<category>Pharyngeal Diseases</category>

<category>Prostatic Neoplasms</category>

<category>Rhizopus</category>

</item>






<item>
<title>Parathyroid hormone assay in fine-needle aspirate is useful in differentiating inadvertently sampled parathyroid tissue from thyroid lesions</title>
<link>http://escholarship.umassmed.edu/pathology_pp/11</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/11</guid>
<pubDate>Fri, 03 Sep 2010 06:15:14 PDT</pubDate>
<description>
	<![CDATA[
	<p>To assess the utility of chemical analysis for parathyroid hormone in the rinse (PTH-r) obtained via fine-needle aspiration (FNA) in the setting of inadvertently sampled parathyroid tissue or lesions (PTL) during "thyroid" or "neck" FNA, the authors review their experience at a large, tertiary care academic medical center. All cases of inadvertent sampling of PTL during "thyroid" or "neck" FNA were identified by computer search. The cytologic and histologic material was reviewed and pertinent clinical data including patient demographics, serum calcium, intact serum PTH (PTH-s), and intact PTH-r was recorded. The cytologic interpretations and histologic diagnoses were also recorded. Of 3,521 cases of total thyroid and neck FNA during the study 21 (0.59%) cases of histologically confirmed sampling of PTL were identified. In all 10 cases with PTH-r the level was markedly elevated (range 248-240,075 pg/mL) and in every case PTH-r/PTH-s was elevated (range 3.67-458.3). In all 10 cases with PTH-r the cytologic diagnosis was PTL or included PTL in the differential. In 4/11 cases without PTL-r diagnoses of thyroid neoplasm or suspicious for thyroid neoplasm were rendered, each resulting in thyroidectomy. PTH-r has utility in differentiating PTL from thyroid lesions in the setting of inadvertent sampling of PTL during thyroid or neck FNA. Cellular specimens with features not typical for thyroid lesions should be triaged for PTL-r. Routine use of PTH-r will result in appropriate triage of patients to less aggressive excisional biopsies rather than unnecessary thyroidectomy.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Adenoma</category>

<category>Adult</category>

<category>Aged</category>

<category>Biopsy, Fine-Needle</category>

<category>Calcium</category>

<category>Diagnostic Errors</category>

<category>Female</category>

<category>Humans</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Parathyroid Glands</category>

<category>Parathyroid Hormone</category>

<category>Parathyroid Neoplasms</category>

<category>Retrospective Studies</category>

<category>Thyroid Gland</category>

<category>Thyroid Neoplasms</category>

</item>






<item>
<title>&quot;Low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion&quot; is a distinct cytologic category: histologic outcomes and HPV prevalence</title>
<link>http://escholarship.umassmed.edu/pathology_pp/10</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/10</guid>
<pubDate>Fri, 03 Sep 2010 06:15:14 PDT</pubDate>
<description>
	<![CDATA[
	<p>We examined the histologic outcomes and prevalence of high-risk human papillomavirus (HR-HPV) in women with liquid-based Papanicolaou (Pap) tests interpreted as "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" (LSIL-H) compared with the 2001 Bethesda System (TBS 2001) cytologic categories of LSIL, high-grade SIL (HSIL), and atypical squamous cells, cannot exclude HSIL (ASC-H). A computer search identified 426 LSIL, 86 ASC-H, 81 LSIL-H, and 110 HSIL cytologic interpretations during a 1-year period, each with up to 2 years of histologic follow-up. The risk of histologic cervical intraepithelial neoplasia (CIN) 2 or worse (CIN 2+) associated with LSIL-H (32/81 [40%]) was intermediate between LSIL (46/426 [10.8%]) and HSIL (72/110 [65.5%]), but not significantly different from ASC-H (23/86 [27%]). However, LSIL-H was more frequently associated with a definitive histologic diagnosis of any CIN (CIN 1+) than ASC-H (53/81 [65%] vs 35/86 [41%]). Moreover, the prevalence of HR-HPV was significantly greater in patients with LSIL-H than in patients with ASC-H (15/15 [100%] vs 43/73 [59%]). The histologic outcomes and HR-HPV prevalence associated with LSIL-H differ significantly from the established categories of TBS 2001 and provide evidence to support the recognition of LSIL-H as a distinct cytologic category.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Alphapapillomavirus</category>

<category>Cervical Intraepithelial Neoplasia</category>

<category>Female</category>

<category>Follow-Up Studies</category>

<category>Humans</category>

<category>Prevalence</category>

<category>Risk Factors</category>

<category>Vaginal Smears</category>

</item>






<item>
<title>Mucinous tubular and spindle cell carcinoma of the kidney: cytopathologic findings</title>
<link>http://escholarship.umassmed.edu/pathology_pp/9</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/9</guid>
<pubDate>Fri, 03 Sep 2010 06:15:14 PDT</pubDate>
<description>
	<![CDATA[
	<p>A 54-year-old woman was hospitalized for flank pain and acute renal failure when imaging studies revealed a 5.2 cm mass in the left kidney. She was referred for fine needle aspiration of the lesion, which showed an epithelial tumor with round to oval nuclei associated with strands of metachromatic stromal tissue. Cytopathologic diagnosis was consistent with renal cell carcinoma. Subsequent nephrectomy was performed and the surgical pathology specimen showed a mucinous tubular and spindle cell carcinoma of the kidney. The patient has done well post-operatively with 10 months of benign follow-up.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Adenocarcinoma</category>

<category>Adenocarcinoma, Mucinous</category>

<category>Biopsy, Fine-Needle</category>

<category>Carcinoma</category>

<category>Female</category>

<category>Humans</category>

<category>Kidney Neoplasms</category>

<category>Middle Aged</category>

</item>






<item>
<title>Cytopathologic findings in &quot;POEMS&quot; syndrome associated with Castleman disease</title>
<link>http://escholarship.umassmed.edu/pathology_pp/8</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/8</guid>
<pubDate>Fri, 03 Sep 2010 06:15:13 PDT</pubDate>
<description>
	<![CDATA[
	<p>A 34-year-old man with a history of a scorpion bite followed by increasing polyneuropathy and IgG lambda monoclonal gammopathy was referred for fine-needle aspiration of a lytic bone lesion and an enlarged axillary lymph node. The findings in the bone lesion were consistent with a plasmacytoma. The FNA of the lymph node showed a peculiar capillary proliferation in a background of polymorphous mature lymphocytes. Flow cytometric analysis showed a mixed lymphoid population. The lymph node was originally signed out descriptively, but review of the case showed features consistent with Castleman disease. After the pathologic findings and clinical features were discussed with the clinical team, the diagnosis of POEMS syndrome was established. Subsequent surgical excision of the lymph node was diagnosed as hyaline vascular-variant Castleman disease.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Adult</category>

<category>Animals</category>

<category>Biopsy, Fine-Needle</category>

<category>Bites and Stings</category>

<category>Bone Diseases</category>

<category>Diagnosis, Differential</category>

<category>Giant Lymph Node Hyperplasia</category>

<category>Humans</category>

<category>Immunoglobulin G</category>

<category>Immunoglobulin lambda-Chains</category>

<category>Immunohistochemistry</category>

<category>Lymph Nodes</category>

<category>Male</category>

<category>Meningitis, Aseptic</category>

<category>Monoclonal Gammopathy of Undetermined Significance</category>

<category>POEMS Syndrome</category>

<category>Plasmacytoma</category>

<category>Polyradiculoneuropathy, Chronic Inflammatory Demyelinating</category>

<category>Scapula</category>

<category>Scorpions</category>

</item>






<item>
<title>Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration</title>
<link>http://escholarship.umassmed.edu/pathology_pp/7</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/7</guid>
<pubDate>Fri, 03 Sep 2010 06:15:13 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND: Deep fibromatosis or desmoid tumor (DF/DT) is a low-grade, soft tissue lesion that is notable for its infiltration and local recurrence and its inability to metastasize. Although the histologic features of DF/DT are well described, there is a paucity of literature regarding cytologic findings.</p>
<p>METHODS: The surgical pathology files of The Johns Hopkins Hospital revealed 17 patients with a diagnosis of DF/DT with prior cytology in a 16-year period (1989-2005). The clinicoradiologic findings were noted, and the fine-needle aspiration (FNA) slides were available for review in 8 patients. In patients with archived tissue, an immunohistochemical panel was performed that included beta-catenin, desmin, CD-34, and c-kit.</p>
<p>RESULTS: There was a wide age range and a wide range of anatomic distribution for DF/DT in this series. Eleven patients (65%) had a prior history of surgery at or near the site of DF/DT. Radiologically, 5 of 11 patients (45%) who had in-house studies available and no history of DF/DT were diagnosed as suspicious for malignancy. Predominantly bland spindled cells with long, fusiform nuclei and metachromatic matrix material were present in most tumors. The tumor cells were present both singly and as fragments embedded in the matrix. Nine patients had paraffin-embedded tissue samples available for immunohistochemical staining. Six of those samples demonstrated nuclear beta-catenin reactivity, and all 9 samples were negative for desmin, CD-34, and c-kit.</p>
<p>CONCLUSIONS: The current results indicated that clinical history in patients with suspected DF/DT is important. Because of the infiltrative nature of DF/DT, the radiographic impression often is over-called as suspicious for malignancy. The cytomorphology is nonspecific, often resulting in descriptive diagnoses. Immunohistochemical stains increase the yield of FNA.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Adolescent</category>

<category>Adult</category>

<category>Aged</category>

<category>Antigens, CD34</category>

<category>Biopsy, Fine-Needle</category>

<category>Child</category>

<category>Desmin</category>

<category>Diagnosis, Differential</category>

<category>Female</category>

<category>Fibromatosis, Aggressive</category>

<category>Humans</category>

<category>Immunohistochemistry</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Proto-Oncogene Proteins c-kit</category>

<category>beta Catenin</category>

</item>






<item>
<title>Distinguishing prostatic from colorectal adenocarcinoma on biopsy samples: the role of morphology and immunohistochemistry</title>
<link>http://escholarship.umassmed.edu/pathology_pp/6</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/6</guid>
<pubDate>Fri, 03 Sep 2010 06:15:13 PDT</pubDate>
<description>
	<![CDATA[
	<p>CONTEXT: Poorly differentiated carcinoma on prostate or colorectal biopsy can occasionally present a diagnostic challenge in determining tumor source especially in locally advanced colorectal carcinoma (CRCa) or prostate carcinoma (PCa). Such determination can affect prognosis and therapy.</p>
<p>OBJECTIVE: To evaluate the role of morphology and immunohistochemistry in the previously mentioned setting.</p>
<p>DESIGN: Surgical pathology and consultation records. Hematoxylin-eosin sections were reviewed in 16 cases (11 PCa, 5 CRCa). Immunohistochemistry for 9 markers was performed in 15 cases.</p>
<p>RESULTS: Dirty necrosis, seen in 5 (100%) of 5 CRCa and 2 (18%) of 11 PCa cases, and the presence of columnar cells with basal nuclei, seen in 5 (100%) of 5 CRCa and 1 (9%) of 11 PCa cases, appear to be the most useful morphologic parameters. Immunohistochemistry confirmed the value of prostate-specific antigen (PSA), CDX2, cytokeratin (CK) 20, and beta-catenin in the differential of CRCa (0% PSA+, 60% CDX2+, 80% CK20+, and 100% beta-catenin+) versus PCa (80% PSA+, 0% CDX2+, 10% CK20+, and 0% beta-catenin+). P501S had a similar sensitivity as PSA in detecting PCa (80%). Two (20%) of 10 PCa cases were positive for 1 of the 2 markers but not the other. P501S was negative in all 5 cases of CRCa.</p>
<p>CONCLUSIONS: P501S is a useful marker in this setting when included together with PSA, CDX2, CK20, and beta-catenin. P501S labels a subset of PCa cases that are negative for PSA. Dirty necrosis and/or columnar cells with basal nuclei could also be of help.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Adenocarcinoma</category>

<category>Adult</category>

<category>Aged</category>

<category>Aged, 80 and over</category>

<category>Colorectal Neoplasms</category>

<category>Diagnosis, Differential</category>

<category>Homeodomain Proteins</category>

<category>Humans</category>

<category>Immunohistochemistry</category>

<category>Keratin-20</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Prostate-Specific Antigen</category>

<category>Prostatic Neoplasms</category>

<category>Sensitivity and Specificity</category>

<category>Tumor Markers, Biological</category>

<category>beta Catenin</category>

</item>






<item>
<title>Significance of denuded urothelium in papillary urothelial lesions</title>
<link>http://escholarship.umassmed.edu/pathology_pp/5</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/5</guid>
<pubDate>Fri, 03 Sep 2010 06:15:13 PDT</pubDate>
<description>
	<![CDATA[
	<p>Flat urothelial carcinoma in situ (CIS) is often characterized by prominent dyscohesion with some cases having only a few clinging CIS cells remaining on biopsy. The finding of extensive denudation on urothelial biopsies is associated with a risk of CIS on either prior or subsequent biopsies. The significance of denudation in papillary urothelial lesions has not been formally studied. We identified from our surgical pathology files 31 specimens (from 28 patients) of papillary urothelial lesions with extensive denudation. In cases in which denudation was associated with low-grade urothelial neoplasms, follow-up of subsequent cytologic and histologic specimens was obtained. Of the 28 patients, 25 (89%) were men and 3 (11%) were women with an age range of 40 to 88 years old (mean age 62). Of 31 biopsies, 15 were from anatomically confined areas (ie, renal pelvis, ureter, and urethra). In 22/28 (79%) patients, prominent denudation was associated with high-grade papillary carcinomas, 4/28 (14%) low-grade papillary carcinomas, and 2/28 (7%) papillary urothelial neoplasms of low-grade malignant potential. The average extent of urothelial denudation was 82% with 61% of cases having > or =90% denudation. Prominent cautery artifact was present in 17/31 (55%) cases. In 13/28 patients with high-grade lesions, there was a concurrent biopsy of a second urothelial lesion that was either high-grade papillary urothelial carcinoma or invasive urothelial carcinoma. Five of the 6 patients in which the prominent denudation was associated with a low-grade papillary urothelial lesion have not progressed to a high-grade lesion. One patient with a denuded papillary urothelial neoplasm of low malignant neoplasm was subsequently diagnosed with a noninvasive low-grade papillary urothelial carcinoma in the bladder and a high-grade infiltrating urothelial carcinoma of the ureter. We conclude that (1) the majority of papillary urothelial lesions associated with prominent urothelial denudation are high grade; (2) a significant percentage of papillary urothelial lesions with denudation occur with either prominent cautery artifact or in anatomically confined areas, suggesting both iatrogenic and mechanical contributing factors, respectively; (3) a minority of cases with prominent urothelial denudation occur in association with low-grade papillary urothelial lesions and are not associated with progression to higher grade lesions on follow-up studies; and (4) prominent urothelial denudation in papillary lesions should prompt careful examination of these specimens for rare clinging high-grade carcinoma cells, although in a minority of cases the underlying lesion will be low grade.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Adult</category>

<category>Aged</category>

<category>Aged, 80 and over</category>

<category>Biopsy</category>

<category>Carcinoma in Situ</category>

<category>Carcinoma, Papillary</category>

<category>Female</category>

<category>Humans</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Precancerous Conditions</category>

<category>Retrospective Studies</category>

<category>Urologic Neoplasms</category>

<category>Urothelium</category>

</item>






<item>
<title>Histologic and electron microscopy findings in myocardium of treated Fabry disease</title>
<link>http://escholarship.umassmed.edu/pathology_pp/4</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/4</guid>
<pubDate>Fri, 03 Sep 2010 06:15:12 PDT</pubDate>
<description>
	<![CDATA[
	<p>The well-described histologic and electron microscopic findings in Fabry disease cardiomyopathy are hypertrophic vacuolated cells with electron dense concentric lamellar bodies. We present altered findings in an endomyocardial biopsy from a patient with treated Fabry disease. A 51-year-old male with Fabry disease, treated with recombinant alpha-galactosidase enzyme replacement therapy for over 18 months, underwent an endomyocardial biopsy for heart failure. The histologic changes showed widespread hypertrophy and vacuolization with rare eosinophilic bodies. Electron microscopy failed to reveal the characteristic globotriaosylceramide concentric lamellar bodies (myelin figures) in the sarcoplasm. Instead, extensive aggregates and single tubular crystalline structures, giant secondary lysosomes as well as abnormal branched chain glycogen were present. This is the first histologic description of long-standing treated Fabry disease in cardiac myocytes.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Biopsy</category>

<category>Fabry Disease</category>

<category>Follow-Up Studies</category>

<category>Heart Failure</category>

<category>Humans</category>

<category>Isoenzymes</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Myocardium</category>

<category>Myocytes, Cardiac</category>

<category>Time Factors</category>

<category>Treatment Outcome</category>

<category>alpha-Galactosidase</category>

</item>






<item>
<title>Atypical squamous cells in exfoliative urinary cytology: clinicopathologic correlates</title>
<link>http://escholarship.umassmed.edu/pathology_pp/3</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/3</guid>
<pubDate>Fri, 03 Sep 2010 06:15:12 PDT</pubDate>
<description>
	<![CDATA[
	<p>Presence of atypical squamous cells (ASC) in voided urine is an uncommon finding that may be the harbinger of an underlying malignant process. ASCs in urine may precede a de novo histologic diagnosis of malignancy or be the first sign of a recurrence in the lower urinary tract, or the gynecologic tract (in women). This study analyzed all urine cytology specimens with such diagnoses, with reference to their final histologic outcome. All urine cytology cases (n = 17,446) that included ASCs, evaluated at The Johns Hopkins Hospital between 1989 and 2003 (14 yr), were reviewed for diagnoses. ASCs as defined in this study are keratinizing cells with large and hyperchromatic smudgy nuclei, high N/C ratio, abnormal nuclear or cytoplasmic shapes, and densely orangeophilic cytoplasm. These cases lacked the qualitative and quantitative criteria for malignancy. The final reference outcome was determined by subsequent histologic and clinical follow-up. Of these 17,446 urine specimens, 55 cases (0.3%) from 47 patients had ASCs present. Thirty-two of the 47 patients had adequate follow-up. In 8 of these 32 patients (25%), a diagnosis of squamous-cell carcinoma (SCC) of the urinary bladder or urothelial carcinoma (UC) with squamous differentiation was made on subsequent histologic examination. In two cases (6%) a diagnosis of high-grade cervical SCC was established on subsequent follow-up. Twenty two of 32 cases (69%) remained benign on histologic and prolonged clinical follow-up. We conclude that ASCs in urine are rare (0.3% in this series). An interpretation of ASCs in a urine specimen is made when there is insufficient qualitative/quantitative evidence for a carcinoma diagnosis. ASCs in urine are a clinically valid diagnostic category (31% were later diagnosed with SCC). Most patients with urinary ASCs do not develop malignancy and, therefore, these cells may represent a reactive/inflammatory process most commonly due to vaginal contamination (in women) or exfoliation from the distal urethra (in men). Rarely, ASCs may exfoliate from a uterine cervical SCC and, therefore, a pelvic examination should be considered in such patients.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Adult</category>

<category>Aged</category>

<category>Carcinoma, Squamous Cell</category>

<category>Female</category>

<category>Follow-Up Studies</category>

<category>Humans</category>

<category>Male</category>

<category>Middle Aged</category>

<category>Retrospective Studies</category>

<category>Urethral Neoplasms</category>

<category>Urinary Bladder Neoplasms</category>

<category>Urine</category>

</item>






<item>
<title>Metastatic breast carcinoma involving the thyroid gland diagnosed by fine-needle aspiration: a case report</title>
<link>http://escholarship.umassmed.edu/pathology_pp/2</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/2</guid>
<pubDate>Fri, 03 Sep 2010 06:15:12 PDT</pubDate>
<description>
	<![CDATA[
	<p>Secondary involvement of the thyroid gland from a remote primary malignancy is uncommon. The distinction of metastatic carcinoma (MC) or sarcoma from a primary thyroid malignancy is important because the treatment is different. We discuss a case of a 64-yr-old female with a history of breast carcinoma, who presented with pain and swelling in her neck 5 yrs after being diagnosed with breast cancer. She had undergone mastectomy with subsequent chemotherapy and radiation for infiltrating mammary carcinoma. During the 5-yr interval, she had been free of clinically evident metastatic disease. Subsequent work-up revealed two distinct nodules in the left lobe of her thyroid gland as well as a subcutaneous mass in her right shoulder. A fine-needle aspiration (FNA) of the larger thyroid nodule showed malignant epithelial cells with features consistent with breast carcinoma in a background of benign thyroid epithelial cells and colloid. The case was signed out as metastatic breast carcinoma. Subsequent FNA and biopsy of her right shoulder lesion also revealed metastatic breast carcinoma with similar morphology to the material in the thyroid FNA.</p>

	]]>
</description>

<author>Christopher L. Owens et al.</author>


<category>Biopsy, Fine-Needle</category>

<category>Breast Neoplasms</category>

<category> *Carcinoma, Ductal, Breast</category>

<category>Female</category>

<category>Humans</category>

<category>Middle Aged</category>

<category>Neoplasm Metastasis</category>

<category>Thyroid Gland</category>

<category>Thyroid Neoplasms</category>

</item>






<item>
<title>Physicians&apos; emotional intelligence and patient satisfaction</title>
<link>http://escholarship.umassmed.edu/pathology_pp/1</link>
<guid isPermaLink="true">http://escholarship.umassmed.edu/pathology_pp/1</guid>
<pubDate>Fri, 03 Sep 2010 06:15:11 PDT</pubDate>
<description>
	<![CDATA[
	<p>BACKGROUND AND OBJECTIVES: This study investigated the relationship between patient satisfaction and physicians' scores on a test of emotional intelligence.</p>
<p>METHODS: Faculty and resident physicians at a southern medical school completed the Bar-On Emotional Quotient Inventory (EQi). Patient subjects were recruited at the conclusion of an office visit and completed a patient satisfaction survey. Spearman rank order correlations and t tests were used to examine the relationship between global, composite, and subscale scores on the EQi and patient satisfaction. Race, gender, and resident/faculty status were compared via t tests.</p>
<p>RESULTS: When patient satisfaction scores were used to dichotomize physicians into two groups, those with 100% satisfied patients and those with less than 100% satisfaction, only one subscale of EQi, "happiness," was related to higher satisfaction.</p>
<p>CONCLUSIONS: Findings suggest a limited relationship between physicians'scores on a test of emotional intelligence and patient satisfaction. Implications for physician training programs are offered in light of recent focus on physician-patient communication in medical education. Application of emotional intelligence concepts to physician skills and patient attitudes needs further research that may lead to further educational opportunities.</p>

	]]>
</description>

<author>Peggy J. Wagner et al.</author>


<category>*Affect</category>

<category>Communication</category>

<category>Data Collection</category>

<category>Empathy</category>

<category>Family Practice</category>

<category>Female</category>

<category>Health Services Research</category>

<category>Humans</category>

<category>Male</category>

<category>Patient Satisfaction</category>

<category>Personality Inventory</category>

<category> *Physician-Patient Relations</category>

<category>Physicians</category>

<category>United States</category>

</item>





</channel>
</rss>
